News

Sphere Fluidics collaborates with PAA to increase throughput in antibody discovery and cell line development

PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System

Cambridge and Farnborough, UK, 15 January 2019: Sphere Fluidics, a company commercialising single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis. PAA’s S-LAB™ plate handler will be integrated with Sphere Fluidics’ Cyto-Mine® Single Cell Analysis System to help increase throughput in antibody discovery and cell line development.

Cyto-Mine® Single Cell Analysis System (right) and S-LAB™ automated plate handler (left)

Sphere Fluidics’ Cyto-Mine is an automated platform which combines single cell screening, sorting, isolation and clone verification, alleviating the need for separate instruments. Its application programming interface (API), introduced as part of the updated Cyto-Mine Studio Software Suite in 2018, enables easy communication with PAA’s innovative S-LAB automated plate handler. The integration of micro-plate handling with the Cyto-Mine will help to reduce hands-on intervention to further streamline bio-pharmaceutical workflows.

 

Dr Frank Craig, CEO, Sphere Fluidics, commented:Our Cyto-Mine is compatible with 96- and 384-well microtiter plates, providing a high-throughput platform for single cell analysis. By combining this with the easy-to-use automated plate handler from Peak Analysis and Automation we will be able to offer improved throughput capabilities to help reduce timelines in bio therapeutic discovery and cell-line development.”

Dr Malcolm Crook, Technical Director, Peak Analysis and Automation, said: Our small, affordable plate handler with the reliability of a robotic arm will offer users of Sphere Fluidics’ award-winning Cyto-Mine system a simple and flexible solution to further improve workflows and reduce costs associated with a more labor-intensive approach.”

S-LAB and Cyto-Mine will be on display in Washington, DC at SLAS 2019 from 2nd to 6th February 2019 (Booth #1655 and #1429).

For further information about PAA’s lab automation systems, please visit: https://www.paa-automation.com/products/automated-platehandlers/

Peak Analysis and Automation

Caroline Buggisch, Marketing Manager

Tel: +44 (0)1252 373000

Email: caroline.buggisch@paa-automation.com

 

For further information about Sphere Fluidics please contact:

Sphere Fluidics https://www.spherefluidics.com/products/integrated-systems/cyto-mine/

Dr Zoe Nilsson, Global Product Marketing Manager

Tel: +44 (0)1223 804210

Email: zoe.nilsson@spherefluidics.com

 

About Sphere Fluidics www.spherefluidics.com

Sphere Fluidics develops and manufactures single cell analysis and monoclonality assurance systems for biotherapeutic discovery and development.

Sphere Fluidics’ Cyto-Mine® System integrates selective screening of tens of millions of single cells, sorting, isolation and clone verification into a single automated platform to streamline workflows, reduce costs, improve throughput and enable high-value clones to be captured in a single run. Cyto-Mine® is underpinned by the Company’s patented picodroplet technology.

Sphere Fluidics is located in Babraham, Cambridgeshire (UK) and Monmouth Junction, New Jersey (USA). The Company has also internationalized its business via a global network of distributors.